Overview

Apatinib as First -Line Treatment for Advanced Esophagus Cancer

Status:
Unknown status
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
An Exploratory study of Amapinib for patients with advanced esophagus cancer .
Phase:
Phase 2
Details
Lead Sponsor:
Affiliated Hospital of North Sichuan Medical College
Treatments:
Apatinib